Senior insider sale
General Counsel and Secretary at CRISPR THERAPEUTICS AG — senior position signals high conviction
$745.9K
12.39K shares
What this filing means
KASINGER JAMES R. plans to sell 12.39K shares of CRISPR THERAPEUTICS AG valued at approximately $745.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/6/2026ACC: 0001950047-26-010087
Officer· General Counsel and Secretary
Since Feb 2026
12.39K
Shares to sell
$745.9K
Approx. market value
1.99K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/6/2026
1.99KTotal acquired1.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/6/2026 | Stock Option Exercise Cash | 1.99K | — |
| Total | 1.99K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.40K
Market value
$626.5K
9/22/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.99K
Market value
$119.5K
10/6/2026
Total
Units
12.39K
Value
$745.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/22/2026 | 10.40K | $626.5K | — | Completed |
| Planned — Approximate Date | ||||
10/6/2026 | 1.99K | $119.5K | NASDAQ | Planned |
| Total | 12.39K | $745.9K | ||